(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet.
A member of the World Health Organization expert team investigating the origins of the coronavirus in Wuhan says the Chinese side granted full access to all […]
New US Covid-19 cases have declined by 61 percent compared to the peak level on January 8, officials said Friday, as they announced troops were being […]
As several vaccines are rolled out across the world, questions already resolved in the lab are cropping up once again, as governments face the challenges of […]